Not Yet Recruiting
Study of Tislelizumab and Platinum-based Chemotherapy Combination With H1 Receptor Antagonist（Diphenhydramine）in Advanced and Metastatic Non-Small Cell Lung Cancer
NCT06704620
- Conditions
- Advanced and Metastatic NSCLC, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
- Locations
-
- Tianjin Medical University Cancer Institute and Hospital Tianjin, China